CXCR2 has been shown to play a major role in tumor progression by recruiting polymorphonuclear type MDSCs and TANs into the tumor microenvironment in murine models of cancers such as colon cancer, pancreatic cancer, head and neck cancer, and melanoma [196,224,225,226]. This evidence concerns the gene CXCR2 and neoplasm.